Clinical Trial Update: Clinical Exploration Study of YOLT-203 in the Treatment of Type 1 Primary Hyperoxaluria (PH1) [EARLY_Phase 1]

View source ↗

Summary

This is an early-phase 1 clinical trial evaluating YOLT-203 for primary hyperoxaluria type 1, currently recruiting at RenJi Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperoxaluria Type

Drugs mentioned

• YOLT-203

Snippet

Sponsor: RenJi Hospital | Conditions: Type 1 Primary Hyperoxaluria | EARLY_Phase 1 | Status: RECRUITING